Finnegan, Henderson, Farabow, Garrett & Dunner is an intellectual property boutique with the breadth and capability (as well as the nationally recognized status in the practice) of a full-service law firm. The firm maintains one of the leading and most active practices dedicated to PTAB disputes and has been especially noteworthy for its handling of appeals. In addition to its heavy-hitting patent practice, the firm also remains highly regarded for trademark and copyright litigation as well. DC-based Douglas Rettew is one of the go-to litigators for trademark litigation. He has represented some of the largest brands in the world, including Capital One, a client that he has recently been representing in several actions in courts throughout the US. Over the last year he has obtained two permanent injunctions against companies in trademark infringement cases. Other major worldwide clients he has represented in the last year include Nestle, Combe, and Under Armour.
In the life sciences space, the firm is highly regarded, earning top-tier standings in patent litigation and Hatch-Waxman cases for leading industry leading companies in the chemical, pharmaceutical, and biotechnology industries. The DC office also houses Paul Browning and James Monroe who are two patent litigators with extensive experience in Hatch-Waxman disputes. Reston-based partner Charles Lipsey is also deeply involved in patent related litigation and acts as one of the lead partners representing AstraZeneca in its Hatch-Waxman dispute against Zydus Pharmaceuticals regarding the client’s billion-dollar drug FARXIGA.